德国Fresenius Biotech
费森尤斯生物技术：生物制药产品的开发及销售，主要应用于基因、肿瘤、移植和再生医学领域。

 

Fresenius Biotech is dedicated to delivering innovative therapeutics to patients with serious illnesses that have a high degree of unmet need. A focal point of our activities is the development of immunotherapeutic products based on innovative antibody technologies. Our focused approach to research and development combined with our international marketing experience enables us to efficiently bring targeted therapeutics to a global patient population.

Our main areas of research:

Transplantation
Oncology
Our core competencies:

Preclinical research and clinical development
Worldwide registration of biopharmaceuticals
Innovative marketing for specialized indications
Attaining market access for innovative products
Founded in 2003, Fresenius Biotech employs approx. 170 employees in Europe and the USA. Fresenius Biotech is a subsidiary of the Fresenius SE healthcare group.